Business Wire

Synchron Announces Long-Term Safety Results from Fully Implanted Endovascular Brain-Computer Interface Stentrode ™ for Severe Paralysis

NEW YORK--(BUSINESS WIRE)--Synchron, a brain computer interface (BCI) company, today announced the results from a study in which four people with ALS received an implant of Synchron’s Stentrode™ ...
Healio

Synchron raises $200M to advance brain-computer interface tech for paralysis

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...
Business Wire

Synchron’s Stentrode Brain-Computer Interface Receives Breakthrough Device Designation from FDA

Stentrode is the only implantable brain-computer interface that does not require open brain surgery and is currently in clinical trials SAN FRANCISCO & NEW YORK & MELBOURNE, Australia--(BUSINESS WIRE) ...
Time

Synchron Stentrode

Sweeney is a contributor for TIME. Courtesy Synchron Synchron’s brain-computer interface, or BCI, aims to enable people who are paralyzed or have severe motor impairment to control smartphones or ...
BioWorld

Synchron raises $200M to accelerate Stentrode BCI platform

Synchron Inc.'s recent $2 million raise for its Stentrode brain-computer interface platform comes at a pivotal time for the technology. Advances in BCI development, ongoing clinical trials and growing ...